TEM (Tempus AI, Inc.) Stock Financials & Earnings | Market Cap Arena

TEM (Tempus AI, Inc.) Stock Financials & Earnings | Market Cap Arena

TEMTempus AI, Inc.

Mkt Cap$9B

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Revenue (TTM)$1.3B

Net Income (TTM)-$245M

EPS (TTM)-$1.41

Free Cash Flow (TTM)-$404M

Gross Margin69.6%

Op. Margin-18.8%

Net Margin-19.3%

FCF Margin-31.8%

P/S Ratio (TTM)7.1x

P/E Ratio (TTM)—

YoY Rev Growth+83.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$116M	$59M	-$54M
Q2 23	$132M	$72M	-$45M
Q3 23	$136M	$74M	-$45M
Q4 23	$148M	$82M	-$52M
Q1 24	$146M	$78M	-$53M
Q2 24	$166M	$76M	-$533M
Q3 24	$181M	$106M	-$54M
Q4 24	$201M	$122M	-$51M
Q1 25	$256M	$155M	-$69M
Q2 25	$315M	$195M	-$62M
Q3 25	$334M	$206M	-$60M
Q4 25	$367M	$330M	-$48M

Valuation

Quarter	P/S	P/E
Q1 23	26.4x	—
Q2 23	21.4x	—
Q3 23	18.6x	—
Q4 23	17.0x	—
Q1 24	16.1x	—
Q2 24	15.2x	—
Q3 24	14.1x	—
Q4 24	13.0x	—
Q1 25	11.3x	—
Q2 25	9.5x	—
Q3 25	8.2x	—
Q4 25	7.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$66M	-$72M
Q2 23	-$55M	-$65M
Q3 23	-$53M	-$69M
Q4 23	-$40M	-$43M
Q1 24	-$101M	-$107M
Q2 24	-$97M	-$105M
Q3 24	$49M	$49M
Q4 24	-$39M	-$47M
Q1 25	-$106M	-$109M
Q2 25	$44M	$35M
Q3 25	-$120M	-$127M
Q4 25	-$218M	-$203M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$6M
Q2 23	$10M
Q3 23	$16M
Q4 23	$3M
Q1 24	$6M
Q2 24	$8M
Q3 24	$43K
Q4 24	$8M
Q1 25	$3M
Q2 25	$10M
Q3 25	$7M
Q4 25	$15M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+75.1%	+32.2%
Q2 23	+152.5%	+51.7%
Q3 23	+85.6%	+41.2%
Q4 23	+46.8%	+25.8%
Q1 24	+26.1%	+17.5%
Q2 24	+25.3%	+293.9%
Q3 24	+33.0%	+29.7%
Q4 24	+35.8%	+25.7%
Q1 25	+75.4%	+63.0%
Q2 25	+89.6%	-46.2%
Q3 25	+84.7%	+68.0%
Q4 25	+83.0%	+65.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$488M	294.2%
Q3 24	$21M	11.6%
Q4 24	$25M	12.4%
Q1 25	$23M	9.0%
Q2 25	$22M	7.1%
Q3 25	$34M	10.2%
Q4 25	$125M	34.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$44M	$69M
Q2 23	$46M	$71M
Q3 23	$47M	$71M
Q4 23	$49M	$85M
Q1 24	$51M	$80M
Q2 24	$146M	$463M
Q3 24	$58M	$101M
Q4 24	$61M	$111M
Q1 25	$69M	$155M
Q2 25	$76M	$181M
Q3 25	$83M	$183M
Q4 25	$72M	$209M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$303M	$0	$303M
Q1 23	$0	$0	$0
Q3 23	$133M	$0	$133M
Q4 23	$166M	$32M	$198M
Q1 24	$80M	$15M	$95M
Q2 24	$479M	$11M	$490M
Q3 24	$388M	$78M	$466M
Q4 24	$341M	$107M	$448M
Q1 25	$152M	$67M	$219M
Q2 25	$186M	$105M	$291M
Q3 25	$656M	$104M	$760M
Q4 25	$605M	$150M	$755M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	170M	+0.0%
Q2 23	170M	+0.0%
Q3 23	170M	+0.0%
Q4 23	154M	-9.2%
Q1 24	170M	+10.2%
Q2 24	154M	-9.2%
Q3 24	166M	+7.4%
Q4 24	162M	-2.1%
Q1 25	171M	+5.2%
Q2 25	173M	+1.7%
Q3 25	175M	+0.9%
Q4 25	174M	-0.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	—	—
FY 22	—	—
FY 23	—	—
FY 24	$289K	2K
FY 25	$335K	4K